178 related articles for article (PubMed ID: 38358377)
1. The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model.
van Riet S; Julien A; Atanasov A; Nordling Å; Ingelman-Sundberg M
Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38358377
[TBL] [Abstract][Full Text] [Related]
2. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease.
Jiao J; Sanchez JI; Saldarriaga OA; Solis LM; Tweardy DJ; Maru DM; Stevenson HL; Beretta L
JHEP Rep; 2023 Feb; 5(2):100628. PubMed ID: 36687470
[TBL] [Abstract][Full Text] [Related]
3. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
[TBL] [Abstract][Full Text] [Related]
5. The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis.
Du W; Wang L
Front Immunol; 2022; 13():936196. PubMed ID: 35837401
[TBL] [Abstract][Full Text] [Related]
6. Liver endothelial cells in NAFLD and transition to NASH and HCC.
Velliou RI; Legaki AI; Nikolakopoulou P; Vlachogiannis NI; Chatzigeorgiou A
Cell Mol Life Sci; 2023 Oct; 80(11):314. PubMed ID: 37798474
[TBL] [Abstract][Full Text] [Related]
7. Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis.
Hurrell T; Kastrinou-Lampou V; Fardellas A; Hendriks DFG; Nordling Å; Johansson I; Baze A; Parmentier C; Richert L; Ingelman-Sundberg M
Cells; 2020 Apr; 9(4):. PubMed ID: 32295224
[TBL] [Abstract][Full Text] [Related]
8. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis.
Pingitore P; Sasidharan K; Ekstrand M; Prill S; Lindén D; Romeo S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986904
[TBL] [Abstract][Full Text] [Related]
9. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma.
Li H
Dig Liver Dis; 2022 May; 54(5):598-613. PubMed ID: 34344577
[TBL] [Abstract][Full Text] [Related]
10. Modelling fatty liver disease with mouse liver-derived multicellular spheroids.
van Os EA; Cools L; Eysackers N; Szafranska K; Smout A; Verhulst S; Reynaert H; McCourt P; Mannaerts I; van Grunsven LA
Biomaterials; 2022 Nov; 290():121817. PubMed ID: 36208587
[TBL] [Abstract][Full Text] [Related]
11. Endothelial group IVA phospholipase A
Kawashita E; Ozaki T; Ishihara K; Kashiwada C; Akiba S
Life Sci; 2022 Apr; 294():120355. PubMed ID: 35093339
[TBL] [Abstract][Full Text] [Related]
12. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.
Younossi ZM; Page S; Rafiq N; Birerdinc A; Stepanova M; Hossain N; Afendy A; Younoszai Z; Goodman Z; Baranova A
Obes Surg; 2011 Apr; 21(4):431-9. PubMed ID: 20532833
[TBL] [Abstract][Full Text] [Related]
13. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis.
Guo Q; Furuta K; Islam S; Caporarello N; Kostallari E; Dielis K; Tschumperlin DJ; Hirsova P; Ibrahim SH
Front Immunol; 2022; 13():983255. PubMed ID: 36091042
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model.
Redenšek Trampuž S; van Riet S; Nordling Å; Ingelman-Sundberg M
Sci Rep; 2024 Jan; 14(1):1396. PubMed ID: 38228622
[TBL] [Abstract][Full Text] [Related]
15. HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia.
Povero D; Chen Y; Johnson SM; McMahon CE; Pan M; Bao H; Petterson XT; Blake E; Lauer KP; O'Brien DR; Yu Y; Graham RP; Taner T; Han X; Razidlo GL; Liu J
J Hepatol; 2023 Aug; 79(2):378-393. PubMed ID: 37061197
[TBL] [Abstract][Full Text] [Related]
16. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B
J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
[TBL] [Abstract][Full Text] [Related]
17. Human centenarian-associated SIRT6 mutants modulate hepatocyte metabolism and collagen deposition in multilineage hepatic 3D spheroids.
Frohlich J; Raffaele M; Skalova H; Leire E; Pata I; Pata P; Gorbunova V; Vinciguerra M
Geroscience; 2023 Apr; 45(2):1177-1196. PubMed ID: 36534275
[TBL] [Abstract][Full Text] [Related]
18. Understanding the cellular interactome of non-alcoholic fatty liver disease.
Wallace SJ; Tacke F; Schwabe RF; Henderson NC
JHEP Rep; 2022 Aug; 4(8):100524. PubMed ID: 35845296
[TBL] [Abstract][Full Text] [Related]
19. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
Li BH; He FP; Yang X; Chen YW; Fan JG
Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in the progression of non-alcoholic fatty liver disease.
Lefere S; Devisscher L; Geerts A
Acta Gastroenterol Belg; 2020; 83(2):301-307. PubMed ID: 32603050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
